feed,title,long_url,short_url
Benzinga,"After Disappointing Phase 2 Data, Merck Drops Eye Disease Related Pact With NGM Biopharm",https://benzinga.com/general/biotech/22/12/30160904/after-disappointing-phase-2-data-merck-drops-eye-disease-related-pact-with-ngm-biopharm,https://da.gd/pwNwV
Benzinga,Why This Housing Downturn Isn't Like 2008,https://benzinga.com/real-estate/22/12/30119850/why-this-housing-downturn-isnt-like-2008,https://da.gd/8PbJp
